28th Apr 2014 09:21
LONDON (Alliance News) - Tissue Regenix Group PLC said Monday that it had won a patent to cover the use of its dCELL technology for mensical implants in China. Mensical implants are used to replace the menisci, the cartilage that acts as a shock absorber in the knee joint. The company Read More
